High constitutive activity of the human formyl peptide receptor

被引:89
作者
Wenzel-Seifert, K [1 ]
Hurt, CM [1 ]
Seifert, R [1 ]
机构
[1] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA
关键词
D O I
10.1074/jbc.273.37.24181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The formyl peptide receptor (FPR) couples to pertussis toxin (PTX)-sensitive Gi-proteins to activate chemotaxis and exocytosis in neutrophils. PTX reduces not only formyl peptide-stimulated but also agonist-independent ("basal") G(i)-protein activity, suggesting that the FPR is constitutively active. We aimed at identifying an inverse FPR agonist, i.e. a compound that suppresses constitutive FPR activity. In Sf9 insect cell membranes, the G-protein heterotrimer G(i)alpha(2)beta(1)gamma(2) reconstituted N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)stimulated guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding and GTP gamma S-sensitive high affinity [H-3]FMLP binding. The FPR "antagonist" cyclosporin H (CsH) potently and efficiently reduced basal GTP gamma S binding in Sf9 membranes. Another FPR antagonist, N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine did not inhibit basal GTP gamma S binding but blocked the inhibitory effect of CsH on GTP gamma S binding. Na+ reduced basal GTP gamma S binding and eliminated the inhibitory effect of CsH. Similar effects of FMLP, CsH, and Na+ as in Sf9 membranes were observed with FPR expressed in the mammalian cell line HEK293. Our data show that the human FPR possesses high constitutive activity. CsH is an inverse FPR agonist and stabilizes the FPR in an inactive state. Na+ also stabilizes the FPR in an inactive state and, thereby, diminishes inverse agonist efficacy.
引用
收藏
页码:24181 / 24189
页数:9
相关论文
共 83 条
  • [51] ACTIVATION OF CALCIUM CURRENTS IN CARDIAC MYOCYTES BY EMPTY BETA-ADRENOCEPTORS
    MEWES, T
    DUTZ, S
    RAVENS, U
    JAKOBS, KH
    [J]. CIRCULATION, 1993, 88 (06) : 2916 - 2922
  • [52] MUKAI H, 1992, J BIOL CHEM, V267, P16237
  • [53] MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113
  • [54] NACCACHE PH, 1991, BLOOD, V78, P2534
  • [55] Receptors induce chemotaxis by releasing the βγ subunit of Gi, not by activating Gq or Gs
    Neptune, ER
    Bourne, HR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14489 - 14494
  • [56] NEVE KA, 1991, MOL PHARMACOL, V39, P733
  • [57] HUMAN SEROTONIN(1B) RECEPTOR EXPRESSION IN SF9 CELLS - PHOSPHORYLATION, PALMITOYLATION, AND ADENYLYL-CYCLASE INHIBITION
    NG, GYK
    GEORGE, SR
    ZASTAWNY, RL
    CARON, M
    BOUVIER, M
    DENNIS, M
    ODOWD, BF
    [J]. BIOCHEMISTRY, 1993, 32 (43) : 11727 - 11733
  • [58] Functional evidence of inverse agonism in vascular smooth muscle
    Noguera, MA
    Ivorra, MD
    DOcon, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (01) : 158 - 164
  • [59] BINDING OF LOW-AFFINITY N-FORMYL PEPTIDE RECEPTORS TO G-PROTEIN - CHARACTERIZATION OF A NOVEL INACTIVE RECEPTOR INTERMEDIATE
    PROSSNITZ, ER
    SCHREIBER, RE
    BOKOCH, GM
    YE, RD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) : 10686 - 10694
  • [60] PIGMENTATION PHENOTYPES OF VARIANT EXTENSION LOCUS ALLELES RESULT FROM POINT MUTATIONS THAT ALTER MSH RECEPTOR FUNCTION
    ROBBINS, LS
    NADEAU, JH
    JOHNSON, KR
    KELLY, MA
    ROSELLIREHFUSS, L
    BAACK, E
    MOUNTJOY, KG
    CONE, RD
    [J]. CELL, 1993, 72 (06) : 827 - 834